ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
63,880.22
0.74%
S&P 500
5,099.96
1.02%
Dow Jones
38,239.66
0.40%
US Dollar vs Yen
158.095
0.00%
Brent Oil
88.165
0.00%
Registration Strip Icon for default 登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ
  6. XORTX Therapeutics Inc (XRTX)

  7. XORTX Therapeutics Inc (XRTX) ニュース

XRTX XORTX Therapeutics Inc

2.93
0.34 (13.13%)
2024年4月27日 - 終了
15分遅延
名称 銘柄コード 市場 種別
XORTX Therapeutics Inc XRTX NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
Upgrade Icon
0.34 13.13% 2.93 13:00:11
始値 安値 高値 終値 前日終値
2.75 2.5301 3.00 2.93 2.59
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/4/2220:00GLOBEXORTX Announces Publication of Key Research in ADPKD
2024/4/0820:30GLOBEXORTX Welcomes New Member to the Board of Directors
2024/4/0820:00GLOBEXORTX Announces Participation in Spring 2024 Investor..
2024/3/2718:00GLOBEXORTX Announces New Clinical Advisory Board Member
2024/3/1918:00GLOBEXORTX Highlights Achievements of 2023 and Preparation for..
2024/3/1120:00GLOBEXORTX Reprices Warrants Issued in Connection with Previous..
2024/3/0421:00GLOBEXORTX Finalizes $2.7 Million Prospectus Supplement and..
2024/2/1521:00GLOBEXORTX Raises $2.5 Million Under Prospectus Supplement and..
2024/2/0210:46GLOBEXORTX Files an Amended and Restated Prospectus Supplement..
2024/1/1521:00GLOBEXORTX Announces $2 Million Public Offering
2024/1/0321:25EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/1/0321:00GLOBEXORTX Submits a New Patent for the Treatment of Chronic..
2024/1/0222:12EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/1/0221:00GLOBEXORTX Welcomes New Member to the Board of Directors
2023/12/0106:04EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/11/3021:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/11/3021:30GLOBEXORTX Announces US ATM Offering
2023/11/3011:57EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2023/11/2921:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/11/2921:00GLOBEXORTX Meets Nasdaq Continued Listing Requirements
2023/11/1321:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/11/1021:00GLOBEXORTX Clarifies Timing for Share Consolidation
2023/11/0907:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/11/0907:00GLOBEXORTX Announces Share Consolidation
2023/11/0220:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/11/0220:00GLOBEXORTX Sponsored Study Presented at the American Society of..
2023/10/2806:30GLOBEXORTX Announces Results of Special Meeting of Shareholders
2023/10/2606:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/10/2606:00GLOBEXORTX Announces Date for Rescheduled Special Meeting of..
2023/10/2520:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/10/2520:00GLOBEXORTX Announces Rescheduling of Special Meeting of..
2023/10/1220:41EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/10/1220:00GLOBEXORTX Reports that Independent Proxy Firm, ISS, Recommends..
2023/10/0502:11EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/10/0420:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/10/0420:00GLOBEXORTX Calls Special Meeting of Shareholders
2023/9/2820:56EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/9/2820:00GLOBEXORTX Sponsored Study Selected for Presentation at the..
2023/9/1304:56EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/9/1120:00GLOBEXORTX Announces Participation at Upcoming Investor..
2023/9/0721:23EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/9/0720:00GLOBEXORTX Joins the Kidney Foundation and Kidney March
2023/8/2920:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/8/2920:00GLOBEXORTX Submits Orphan Drug Designation Application to the..
2023/8/2519:00EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
2023/8/1505:42EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
2023/8/1505:40EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
2023/8/0813:15EDGAR2Form EFFECT - Notice of Effectiveness
2023/8/0506:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/8/0506:00GLOBEXORTX Appoints Chief Financial Officer

最近閲覧した銘柄

NASDAQ
XRTX
XORTX Therapeutics
Delayed Upgrade Clock
ADVFN Logo

日本
会社情報
ビジネス
人気
アプリを入手

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有